Page last updated: 2024-10-30

lorazepam and Kidney Diseases

lorazepam has been researched along with Kidney Diseases in 2 studies

Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.

Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.

Research Excerpts

ExcerptRelevanceReference
"Propylene glycol accumulation was defined as concentrations of 25 mg/dL or more."1.35Propylene glycol accumulation in critically ill patients receiving continuous intravenous lorazepam infusions. ( Fish, DN; Horinek, EL; Kiser, TH; MacLaren, R, 2009)
" Lorazepam kinetics after subchronic dosing were linear."1.27Effect of renal impairment and hemodialysis on lorazepam kinetics. ( Chiang, ST; Koepke, HH; Morrison, G; Walker, BR, 1984)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Horinek, EL1
Kiser, TH1
Fish, DN1
MacLaren, R1
Morrison, G1
Chiang, ST1
Koepke, HH1
Walker, BR1

Other Studies

2 other studies available for lorazepam and Kidney Diseases

ArticleYear
Propylene glycol accumulation in critically ill patients receiving continuous intravenous lorazepam infusions.
    The Annals of pharmacotherapy, 2009, Volume: 43, Issue:12

    Topics: Adult; Age Factors; Aged; Critical Illness; Dose-Response Relationship, Drug; Female; Humans; Hypnot

2009
Effect of renal impairment and hemodialysis on lorazepam kinetics.
    Clinical pharmacology and therapeutics, 1984, Volume: 35, Issue:5

    Topics: Administration, Oral; Adult; Aged; Biotransformation; Feces; Glomerular Filtration Rate; Humans; Inj

1984